Core Viewpoint - The legal opinion issued by Guangdong Xinda Law Firm confirms that Shenzhen Xinlong Health Industry Development Co., Ltd. has obtained the necessary approvals for the repurchase and cancellation of certain restricted stocks under its 2023 incentive plan, pending final approval from the shareholders' meeting [1][9]. Group 1: Approval and Authorization - On June 15, 2023, the company held its first extraordinary general meeting of shareholders, which approved the 2023 restricted stock incentive plan and authorized the board of directors to implement the plan [2][3]. - The board is authorized to handle various matters related to the incentive plan, including adjustments to the number and price of restricted stocks in case of stock splits or dividends [3][4]. Group 2: Specifics of the Repurchase - The company plans to repurchase and cancel a total of 1,818,050 shares of restricted stock, which includes 75,000 shares from two departing incentive recipients and 1,743,050 shares that did not meet the release conditions [5][6]. - The repurchase price for the restricted stocks is set at 3.49 yuan per share, adjusted from the previous price of 3.52 yuan [4][5]. Group 3: Performance Targets and Conditions - The incentive plan stipulates that the release of restricted stocks is contingent upon meeting specific performance targets, including a revenue growth rate of no less than 5% for 2024 and 10% for 2025, based on 2022 revenue [7][8]. - The actual performance for the first release period did not meet the targets, leading to the cancellation of the corresponding restricted stocks [9]. Group 4: Legal Compliance - The legal opinion asserts that the repurchase and cancellation of restricted stocks comply with the Company Law, Securities Law, and relevant regulations, but still requires approval from the shareholders' meeting [9][10].

中国上海石门一路 288 号 兴业太古汇香港兴业中心一座 26 层 邮编：200041 电话：（86-21）5298 5488 传真：（86-21）5298 5492 君合律师事务所上海分所 关于益方生物科技（上海）股份有限公司 成就的法律意见书 益方生物科技（上海）股份有限公司： 君合律师事务所上海分所（以下简称"本所"）接受益方生物科技（上海） 股份有限公司（以下简称"公司"或"益方生物"）的委托，担任益方生物 2022 年限制性股票激励计划（以下简称"本次激励计划"）的专项法律顾问，根据《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 （以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简称"《管 理办法》"）、《上海证券交易所科创板股票上市规则》（以下简称"《上市规 则》"）、《科创板上市公司自律监管指南第 4 号——股权激励信息披露》（以 下简称"《自律监管指南》"）以及中华人民共和国（包括香港特别行政区、澳 门特别行政区和台湾地区，仅为出具本法律意见书之目的，特指中华人民共和国 大陆地区，以下简称"中国"）其他相关法律、法规及规范性文件的有关规定， 就本次激 ...

证券代码：688382 证券简称：益方生物 公告编号：2025-030 益方生物科技（上海）股份有限公司 关于 2022 年限制性股票激励计划预留授予部分第二 个归属期符合归属条件的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 限制性股票拟归属数量：2.0647 万股 ? 归属股票来源：向激励对象定向发行的益方生物科技（上海）股份有 限公司（以下简称"公司"）人民币 A 股普通股股票 一、本次股权激励计划批准及实施情况 （一）本次股权激励计划方案及履行的程序 （1）激励方式：第二类限制性股票 （2）授予数量：553.4115 万股，其中首次授予 461.1762 万股，预留授予 （3）授予价格：4.35 元/股 （4）激励人数：首次授予 71 人，预留授予合计 30 人 （5）本次激励计划首次授予的限制性股票的归属期限和归属安排具体如下： 归属期 归属安排 归属比例 自首次授予部分限制性股票授予日起 12 个月后的 第一个归属期 首个交易日起至首次授予部分限制性股票授予日起 40% 自首次授予部 ...

Core Viewpoint - Shanghai Huaneng Technology Co., Ltd. is repurchasing and canceling a total of 3,498,600 restricted stocks due to the retirement and job changes of certain employees, as well as unmet performance targets for the third release period [2][4]. Group 1: Reasons and Quantity of Repurchase - The company will repurchase 261,800 restricted stocks from 10 employees who have retired or changed jobs [2]. - Additionally, 3,236,800 restricted stocks will be repurchased from 146 employees due to failure to meet performance targets, with a compound annual growth rate of net profit at 0.01%, below the target of 10% [2]. Group 2: Repurchase Price and Adjustments - The adjusted repurchase price for the restricted stocks is calculated to be 2.34921 yuan per share after accounting for multiple cash dividends distributed from 2021 to 2025 [3]. - For the 10 employees whose stocks are being repurchased due to retirement or job changes, the repurchase price will be 2.34921 yuan per share plus the interest from bank deposits [3]. - For the stocks repurchased due to unmet performance targets, the repurchase price will be the lower of the grant price or the market price at the time of repurchase, set at 2.34921 yuan per share [3]. Group 3: Independent Financial Advisor Opinion - The independent financial advisor confirmed that the repurchase and cancellation of restricted stocks, along with the adjustment of repurchase prices, complied with relevant laws and regulations, and did not harm the interests of the company or its shareholders [4].

Meeting Overview - The board meeting of Fujian Haitong Development Co., Ltd. was held on August 20, 2025, with all 7 directors present, ensuring compliance with legal and regulatory requirements [1]. Resolutions Passed Stock Repurchase and Cancellation - The board approved the repurchase and cancellation of a total of 302,600 restricted stocks and 164,000 stock options due to the departure of certain incentive targets and performance issues [1][2]. Stock Option and Restricted Stock Incentive Plan - The board confirmed that the conditions for the first exercise period of the 2024 stock option and restricted stock incentive plan have been met, allowing 13 eligible individuals to exercise a total of 345,000 stock options [2][3]. Release of Restricted Stocks - The board acknowledged that the conditions for the second release period of the 2023 restricted stock incentive plan have been fulfilled, allowing 38 individuals to apply for the release of 1,336,440 restricted stocks, which represents 0.14% of the company's total share capital [3][4]. Quality Improvement Action Plan - The board reviewed and approved the evaluation report of the "Quality Improvement and Return to Shareholders" special action plan for the first half of 2025, which aligns with national economic directives and aims to enhance the company's development and investment value [4][5]. Organizational Structure Adjustment - The board approved adjustments to the company's organizational structure to improve operational efficiency and governance, authorizing management to implement these changes [5].

Core Viewpoint - The report discusses the completion of the second unlock period conditions for the 2023 restricted stock incentive plan of Fujian Haitong Development Co., Ltd, indicating that necessary approvals and authorizations have been obtained for the unlocking of shares [6][10]. Summary by Sections Independent Financial Advisor's Opinion - The independent financial advisor confirms that the incentive plan has followed the necessary approval procedures and that the independent directors have expressed their agreement [4][5]. - The advisor emphasizes that the plan complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [10]. Conditions for Unlocking Shares - The first unlock period for the restricted stock began on September 19, 2023, and the second unlock period will end on September 18, 2025, with a 30% unlock ratio [6][7]. - The conditions for unlocking include achieving specific performance targets related to domestic and international shipping operations [9][10]. Performance Assessment - The performance targets for unlocking shares include a minimum growth rate of 20% in domestic shipping volume and a minimum growth rate of 35% in international shipping contract operational days [9][10]. - The unlocking of shares is contingent upon both company-level performance and individual performance assessments, with specific criteria outlined for each [10][11]. Shareholder Communication - The company has communicated the details of the incentive plan and the unlocking conditions to shareholders, ensuring transparency and compliance with regulatory requirements [2][3].

Summary of Key Points Core Viewpoint The report discusses the repurchase and cancellation of restricted stocks by Huadian Technology Co., Ltd. and the adjustment of repurchase prices, emphasizing the compliance with relevant regulations and the impact on shareholders. Group 1: Repurchase and Cancellation of Restricted Stocks - The company plans to repurchase and cancel 261,800 shares of restricted stocks from 10 individuals due to retirement or termination of employment [7] - A total of 3,236,800 shares will be repurchased from 146 individuals as the performance targets for the third unlock period were not met [8] - The repurchase of restricted stocks was completed on February 28, 2023, and November 10, 2023, with the necessary approvals obtained from the board and supervisory committee [5][6] Group 2: Adjustment of Repurchase Prices - The adjusted repurchase price for the restricted stocks is calculated to be 2.34921 yuan per share after accounting for cash dividends [10] - The repurchase price for stocks not meeting performance targets will be based on the lower of the grant price or market price at the time of repurchase [10] - The adjustments to the repurchase price are in accordance with the company's stock incentive plan and relevant regulations [9][10] Group 3: Compliance and Approval Procedures - The independent financial advisor confirms that all necessary procedures for the repurchase and cancellation of restricted stocks have been followed, ensuring compliance with laws and regulations [10] - The company has disclosed all relevant information regarding the stock incentive plan to shareholders [2] - Independent opinions from the board and supervisory committee have been obtained for the related proposals [4][5]

福建海通发展股份有限公司 关于 2023 年限制性股票激励计划首次授予第二个 解除限售期解除限售条件成就的公告 证券代码：603162 证券简称：海通发展 公告编号：2025-098 《关于 <福建海通发展股份有限公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案 ="草案"> 及其 摘要的议案》《关于 <福建海通发展股份有限公司 ensp="ensp" 年限制性股票激励计划实="年限制性股 票激励计划实"> 施考核管理办法>的议案》和《关于提请股东大会授权董事会办理 2023 年限制性 股票激励计划相关事宜的议案》，公司独立董事发表了同意的独立意见。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 励计划首次授予第二个解除限售期解除限售条件成就，符合解除限售条件成就的 激励对象共 38 名，可解除限售的限制性股票数量为 1,336,440 股，约占目前公司 总股本的 0.14%。 将发布相关提示性公告，敬请投资者注意。 于 2023 年限制性股票激励计划首次授予第二个解除限售期 ...

Core Points - The company has achieved the conditions for the first unlock period of the 2024 restricted stock incentive plan, allowing 32 eligible participants to unlock a total of 367,080 shares, which represents 0.4695% of the company's total share capital of 78,187,370 shares [1][12][13] - The first unlock period will end on October 17, 2025, and the company has set performance targets for the unlock conditions, including a net profit of no less than 60 million yuan for 2024 [2][9][10] - The company has conducted necessary approvals and legal reviews for the incentive plan, confirming that the unlock conditions have been met and that the process complies with relevant laws and regulations [5][14] Summary by Sections Incentive Plan Overview - The incentive plan is valid for a maximum of 36 months from the date of stock grant, with two unlock periods: the first allows for 50% of the granted shares to be unlocked after 12 months, and the second allows for the remaining 50% after 24 months [2][3] - The performance assessment for the company level is based on net profit targets, with specific figures set for each year [2][10] Performance Assessment - The first unlock period requires a net profit of at least 60 million yuan for 2024, while the second period requires a net profit of at least 75 million yuan for 2025 or a cumulative net profit of at least 135 million yuan over the two years [2][10] - The individual performance assessment will determine the actual number of shares that can be unlocked based on the performance rating of each participant [3][10] Approval Process - The company has followed the necessary procedures for the approval of the incentive plan, including board meetings and legal opinions confirming compliance with regulations [5][14] - The monitoring committee has verified that the conditions for unlocking the shares have been met and that the eligible participants are in compliance with the plan [13][14] Specifics of Unlocking - The unlocking of shares will be processed uniformly for eligible participants, and any shares that do not meet the conditions will be repurchased by the company [4][11] - The total number of shares to be unlocked and the distribution among participants have been detailed, with specific allocations for key personnel [12][13]

Core Viewpoint - The company plans to repurchase and cancel a total of 3,498,600 restricted stocks that have been granted but not yet released from restrictions, adjusting the repurchase price based on previous annual profit distribution [1][2][10] Group 1: Repurchase Details - The number of restricted stocks will decrease from 1,165,722,300 to 1,162,223,700 shares [1] - The repurchase price for the restricted stocks is set at 2.34921 yuan per share, plus the interest from bank deposits [1][9] - The total amount allocated for the repurchase is 8,284,847.06 yuan, sourced from the company's own funds [9] Group 2: Reasons for Repurchase - The repurchase is due to 10 incentive targets retiring or changing positions, leading to the cancellation of 261,800 shares [2][8] - Additionally, 3,236,800 shares will be repurchased because the performance targets for the third release period were not met [2][8] Group 3: Performance Assessment - The performance assessment for the third release period was based on achieving a net asset return rate of at least 2.42% and a compound annual growth rate of net profit of at least 10% from 2019 to 2023 [8] - The actual performance showed a net profit compound growth rate of 0.01%, a net asset return rate of 1.54%, and a negative EVA for 2023 [8] Group 4: Compliance and Approval - The repurchase and cancellation of restricted stocks comply with the relevant regulations of the company's stock incentive plan and have been approved by the board and supervisory committee [10][11] - The proposal still requires approval from the company's shareholders [11]